LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

314

Enrollment

NIH

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: LY3819253
BIOLOGICAL: Placebo
BIOLOGICAL: Remdesivir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]